Price MJ - Search Results

1

Cangrelor for treatment of arterial thrombosis.

Walsh JA 3rd, Price MJ. Walsh JA 3rd, et al. Among authors: price mj. Expert Opin Pharmacother. 2014 Mar;15(4):565-72. doi: 10.1517/14656566.2014.882319. Epub 2014 Jan 30. Expert Opin Pharmacother. 2014. PMID: 24479981 Review.

2

Rescue percutaneous coronary intervention early after coronary artery bypass grafting in the drug-eluting stent era.

Price MJ, Housman L, Teirstein PS. Price MJ, et al. Am J Cardiol. 2006 Mar 15;97(6):789-91. doi: 10.1016/j.amjcard.2005.09.128. Epub 2006 Jan 11. Am J Cardiol. 2006. PMID: 16516577

3

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.

Price MJ, Endemann S, Gollapudi RR, Valencia R, Stinis CT, Levisay JP, Ernst A, Sawhney NS, Schatz RA, Teirstein PS. Price MJ, et al. Eur Heart J. 2008 Apr;29(8):992-1000. doi: 10.1093/eurheartj/ehn046. Epub 2008 Feb 10. Eur Heart J. 2008. PMID: 18263931

4

New antiplatelet therapies in development.

Price MJ. Price MJ. Am J Health Syst Pharm. 2008 Jul 1;65(13 Suppl 5):S11-5; quiz S16-8. doi: 10.2146/ajhp080157. Am J Health Syst Pharm. 2008. PMID: 18574020

5

Antiplatelet therapy in acute coronary syndromes.

Barker CM, Price MJ. Barker CM, et al. Among authors: price mj. Curr Cardiol Rep. 2008 Jul;10(4):327-33. doi: 10.1007/s11886-008-0052-y. Curr Cardiol Rep. 2008. PMID: 18611368

6

Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers.

Price MJ, Teirstein PS. Price MJ, et al. Am J Cardiol. 2008 Sep 15;102(6):790-5. doi: 10.1016/j.amjcard.2008.02.109. Epub 2008 Jul 2. Am J Cardiol. 2008. PMID: 18774008

7

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial.

Price MJ, Berger PB, Angiolillo DJ, Teirstein PS, Tanguay JF, Kandzari DE, Cannon CP, Topol EJ. Price MJ, et al. Am Heart J. 2009 May;157(5):818-24, 824.e1. doi: 10.1016/j.ahj.2009.02.012. Am Heart J. 2009. PMID: 19376306 Clinical Trial.

8

Evaluation of clopidogrel responsiveness after drug-eluting stent implantation.

Price MJ. Price MJ. Minerva Cardioangiol. 2009 Oct;57(5):657-66. Minerva Cardioangiol. 2009. PMID: 19838155

9

Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.

Kandzari DE, Angiolillo DJ, Price MJ, Teirstein PS. Kandzari DE, et al. Among authors: price mj. JACC Cardiovasc Interv. 2009 Dec;2(12):1279-85. doi: 10.1016/j.jcin.2009.09.012. JACC Cardiovasc Interv. 2009. PMID: 20129557 Free article. Review.

10

Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.

Price MJ, Barker CM. Price MJ, et al. Biomark Med. 2011 Feb;5(1):43-51. doi: 10.2217/bmm.11.1. Biomark Med. 2011. PMID: 21319964 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page